CVI’s Dr. William Gwin was interviewed by NBC 10 in Rhode Island about his Phase 1 clinical trial for advanced HER2 positive breast cancer patients. The study is investigating if Alpha-TEA therapy, in combination with the antibody-drug Herceptin, may produce similar results to chemotherapy, but without the side effects.